The Bruce Rickborn-Ross Johnson Endowed Graduate Fellowship Fund was established in 2007 through a generous gift of $500,000 from Dr. M. Ross Johnson, a 1970 Ph.D. Organic Chemistry alum of UC Santa Barbara, and honors his former Ph.D. advisor, Dr. Bruce Rickborn. Dr. Rickborn is widely recognized as one of the most important contributors to building the now world renowned reputation of the Department of Chemistry and Biochemistry at UC Santa Barbara.
Professor Bruce Rickborn received his B.A. from UC Riverside (Charter Student, 1956), and the Ph.D. degree from UCLA (1960), where he worked with Nobel Laureate Donald J. Cram. After two years on the Berkeley faculty, he transferred to Santa Barbara in 1962. Author or co-author of 90 research papers and one book, he points to his continuing warm relationships with over 30 Ph.D. students who obtained degrees under his direction as his most important contribution to science. He has been an A.P. Sloan Fellow, an NSF Senior Postdoctoral Fellow (MPI, Mulheim/Ruhr), and a Fulbright Senior Lecturer (U. Nacional, Bogota). In addition to teaching at all levels, he was drawn into administration in the turbulent times of the late 1960's, eventually serving as Dean of Letters & Science from 1973-1978, where he worked closely with Vice Chancellor Alec Alexander and Chancellor Vernon Cheadle. Dr. Rickborn served the campus and the University in several senate roles, including the Committee on Research and the Review of UC Administration of Weapons Labs, as well as serving on the Board of the Faculty Club for a number of years. Dr. Rickborn retired in 2001 after 39 years of service to the department of Chemistry at UC Santa Barbara. The establishment of the Bruce Rickborn-Ross Johnson Endowed Graduate Fellowship Fund at UC Santa Barbara is intended to honor and celebrate Dr. Rickborn and his tremendous impact on the department and its students, while enabling the department to attract top-notch graduate students.
Dr. M. Ross Johnson received his B.S. Degree in Chemistry from the University of California at Berkeley (1967) and Ph.D. degree in Organic Chemistry from the University of California at Santa Barbara (1970). He is a named inventor on more than 100 U.S. Patents, co-author of more than 50 publications and chapters, and has over 100 invited and abstracted presentations covering drug therapies useful for a wide range of diseases.
Dr. Johnson is currently the CEO, President, and Co-Founder of Parion Sciences, Inc. and resides in Chapel Hill, North Carolina. He is an internationally recognized medicinal chemist with a long and productive career as an inventor, drug discoverer, executive and entrepreneur in the Pharmaceutical and Biotechnology industries. From 1995-1999 he was President, Chief Executive Officer, and Chief Scientific Officer of Trimeris, Inc. (TRMS), a company he took public in 1997. Prior to that, Dr. Johnson was Vice President of Chemistry at Glaxco, Inc. (now GSK) where he was part of the original scientific founding team for Glaxco's research entry into the United States. Previous to GSK, Dr. Johnson served in key scientific and research management positions with Pfizer Central Research (PFE).